Cargando…
The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma—successes and challenges
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264087/ https://www.ncbi.nlm.nih.gov/pubmed/35813761 http://dx.doi.org/10.21037/jtd-22-432 |